Shares of GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $29.29 and traded as low as $28.77. GENMAB A/S/S shares last traded at $29.43, with a volume of 342,399 shares changing hands.
GENMAB A/S/S Stock Performance
The stock’s 50-day moving average price is $29.30 and its 200-day moving average price is $30.37.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Stories
- Five stocks we like better than GENMAB A/S/S
- Earnings Per Share Calculator: How to Calculate EPS
- Comprehensive PepsiCo Stock Analysis
- 3 Fintech Stocks With Good 2021 Prospects
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Effectively Use the MarketBeat Ratings Screener
- Bear Market Funds to Watch This Year
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.